• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Can J Respir Ther . Respiratory involvement parameters in hospitalized COVID-19 patients and their association with mortality and length of stay

tetano

Editor, Senior Moderator
Can J Respir Ther


. 2022 Jan 13;58:1-8.
doi: 10.29390/cjrt-2021-057. eCollection 2022.
Respiratory involvement parameters in hospitalized COVID-19 patients and their association with mortality and length of stay


Eric Lam[SUP] 1 [/SUP], Sandra Gomez Paz[SUP] 2 [/SUP], Dominique Goddard-Harte[SUP] 1 [/SUP], Yosif N Pak[SUP] 3 [/SUP], Joshua Fogel[SUP] 4 [/SUP], Sofia Rubinstein[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction/background: Patients with Coronavirus Disease 2019 (COVID-19) present with a spectrum of respiratory symptoms. There are no studies describing respiratory system involvement adjusted for other organ systems, oxygen saturation nadir, hospitalization days until respiratory involvement, proportion of days of respiratory system involvement, and persistent respiratory involvement at discharge in COVID-19 patients. We studied these parameters in COVID-19 patients that received respiratory therapy interventions and their association with mortality and length of stay (LOS).
Methods: A single-center cross-sectional retrospective study of 738 COVID-19 patients with respiratory involvement at a hospital in the New York metropolitan area.
Results: COVID-19 patients with respiratory involvement had increased mortality with oxygen requirement of FiO[SUB]2[/SUB] >55% (OR:39.02, 95% CI:1.59-960.51, P < 0.05) and mechanical ventilation (OR:236.64, 95% CI:8.24-6798.93, P < 0.01). Respiratory system involvement adjusted for other organ system involvement was associated with increased mortality (OR:1.60, 95% CI:1.20, 2.14, P < 0.01) and LOS (B = 0.02, SE = 0.01, P < 0.01). Oxygen saturation nadir of 70%-89% was significantly associated with increased LOS (B = 0.07, SE = 0.03, P < 0.05), whereas oxygen saturation nadir of <70% was associated with increased mortality (OR:12.95, 95% CI:2.72-61.61, P < 0.01). An increased proportion of days in hospital with respiratory system involvement was associated with decreased mortality (OR:0.004, 95% CI:<0.001-0.06, P < 0.001) and increased LOS (B = 0.90, SE = 0.07, P < 0.001). Respiratory involvement on days 4-7 was associated with decreased mortality (OR:0.02, 95% CI:<0.003-0.17, P < 0.001), and respiratory involvement on day >1 was associated with increased LOS. Respiratory involvement persistent at discharge was associated with increased mortality (OR:56.82, 95%CI:18.51-174.43, P < 0.001).
Conclusions: Among all respiratory parameters, high oxygen requirements and low oxygen saturation nadir are the most predictive of COVID-19 prognosis.

Keywords: COVID-19; SARS-CoV-2; length of stay; mortality; respiratory system.
 
Back
Top Bottom